News
COVID-19 may discourage pediatric flu vaccination
October 6, 2020
Approximately one-third of parents whose children received no flu vaccine last year said the pandemic made them less likely to vaccinate their children this year.
News
Inside the flawed White House testing scheme that did not protect Trump
October 5, 2020
An early antigen test used by the White House was woefully inaccurate. But the new antigen test the White House is using has not been independently evaluated for accuracy and reliability.
News
Dapagliflozin’s CKD performance sends heart failure messages
October 5, 2020
The recently reported DAPA-CKD trial results focused on patients with renal disease, but the findings also resonate for heart failure clinicians.
News
Real-world safety, efficacy found for fecal transplants
October 2, 2020
The study didn't yield any findings on indications other than Clostridioides difficile. "In no way, shape, or form does it mean you can use it for autism, depression, heart disease, or [irritable bowel syndrome]."
News
Post-COVID clinics get jump-start from patients with lingering illness
October 2, 2020
That need has jump-started post-COVID clinics, which bring together a range of specialists into a one-stop shop.
News
AHA scientific statement highlights cardiorenal benefit of new diabetes drugs
October 1, 2020
SGLT2 inhibitors and GLP-1 receptor agonists should be considered in people with type 2 diabetes and chronic kidney disease to protect against heart disease and kidney disease progression.
News
COVID-19 shutdown fuels sharp rise in alcohol use
September 30, 2020
After some states issued stay-at-home orders, one study noted a 54% increase in national sales of alcohol for the week ending March 21, compared with 1 year earlier.
News
DAPA-CKD resets eGFR floor for safe SGLT2 inhibitor use
September 25, 2020
Until now, SGLT2 inhibitors were for patients with an eGFR of at least 30 mL/min per m2. New evidence moves the threshold down to 25.
News
COVID-19 airway management: Expert tips on infection control
September 24, 2020
“We will always observe standard precautions, which include hand hygiene, gloves, hair and eye cover, medical mask, and face shield,” Dr. Charles Griffis said.
News
J&J’s one-shot COVID-19 vaccine advances to phase 3 testing
September 24, 2020
J&J’s vaccine is unusual in that it will be tested based on a single dose, while other advanced candidates have been tested in two-dose regimens.